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Abstract
Background: Obesity is a pro-inflammatory state that may predispose patients to acute coronary syndrome
characterized by chronic low grade inflammation resulting in endothelial dysfunction (ED). The aim of the study
was to evaluate urinary biomarkers of inflammation and ED in adolescents with obesity.
Methods: Sixty three subjects were recruited for the study. Twenty healthy adolescents with normal body mass
(NW), 14 overweight (OW), 29 obese (OA) subjects were selected. An EndoPat 2000 device was used to measure
the reactive hyperemia index (RHI). First morning fasting urine samples were tested for interleukin 6 (IL-6), endothelin 1
(ET-1), alpha-1-acid glycoprotein (AGP), tumor necrosis factor- α (TNF-α) and corrected to urinary creatinine.
Results: Urinary TNF-α was significantly higher in OA group (52.4 ± 15.3 pg/mg) compared to adolescents with NW
(14.1 ± 1.2 pg/mg, P = 0.04). ET-1 levels were found to be higher in OW (5.18 ± 1.6 pg/mg) compared with NW
(3 · 47 ± 0.3 pg/mg, P = 0.24); and higher in OA (8.48 ± 3.1 pg/mg) compared to both NW (P = 0.19) and OW (P = 0.40).
Similarly a higher AGP level was observed in OW (864.8 ± 156 ng/mg) and OA (808.3 ± 186 ng/mg) compared to NW
(653 ± 69 ng/mg) (P = 0.16 & 0.49 respectively). Inflammatory markers namely, TNF-α, IL-6 and AGP significantly and
positively correlated with each other and with ET-1, a marker for endothelial dysfunction. This significant correlation
was also observed when tested separately in the subgroups (NW, OW and OA). There were no differences in RHI levels
among the study groups.
Conclusion: Urinary TNF-alpha is significantly elevated in obese adolescents and correlates with urinary ET-1, which is
recognized as a biomarker for endothelial dysfunction. Since obesity is a chronic inflammatory state, elevated urinary
TNF-alpha might be used as a non invasive tool to monitor the level of that inflammation.
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Background
Obesity is well known to be major risk factor for the
early development of atherosclerosis and consequently
cardiovascular complications [1, 2]. The prevalence of
this condition among children and adolescents has been
growing at an alarming rate over the last two decades
resulting in huge burden on health care system [1–4].
From 9 to 20% of American children and adoles-
cents are obese. They are likely to be obese in adult-
hood and develop obesity-related health problems
(https://www.cdc.gov/obesity/data/childhood.html).
Obesity has been pointed out as a contributing factor
to approximately 100,000–400,000 deaths in the United
States per year [5].
Obesity beginning at an early age in childhood in-
creases the morbidity associated with it and creates the
tendency for increased risk of chronic diseases such as
cardiovascular disease (CVD). This increased risk of
CVD in obesity has traditionally correlated with major
risk factors such as diabetes, hypertension, and hyper-
lipidemia [6, 7]. These major risk factors are validated
in many populations [8–10] for the diagnosis and man-
agement of CVD. The underlying mechanisms for the
association of obesity and major risk factors with CVD* Correspondence: tetyana.vasylyeva@ttuhsc.edu
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are still not fully understood, but it seems that chronic
low grade inflammation plays a substantial role.
On the other hand, formation of atherosclerosis is a
slow process and starts years before the clinical manifest-
ation. The process starts as early as in the first and second
decades of life in individuals at risk and manifests usually
after the third to fourth decades of life. This fact moti-
vated the clinical researchers over the years to develop a
valid screening test for the early detection and an inter-
vention to abort or at least slow the atherosclerosis forma-
tion before it becomes an irreversible condition [6–8].
It was established that endothelial dysfunction (ED)
represents the early reversible stage in the development
of atherosclerosis. Both obesity and diabetes mellitus
were found to be strongly associated with ED and the
subsequent atherosclerosis formation [9–12].
Chronic low-grade subclinical systemic inflammation
was found in both diabetes and obesity. Those patients
have high serum levels of inflammatory cytokines and
other markers such as IL-6, TNF- α, C-reactive protein,
AGP and few others. The elevated serum levels of in-
flammatory markers were strongly associated with de-
terioration in the endothelial function in obese and
diabetic individuals, suggesting that diabetes and obesity
represent a state of chronic systemic inflammation that
in turn cause ED [13–16]. Multiple studies showed that
reactive hyperemia index (RHI) is good noninvasive indi-
cator of endothelial dysfunction [17–21].
The use of urinary biomarkers as a noninvasive
screening test for systemic diseases outcomes monitor-
ing has gained interest recently. Urinary biomarkers in
obese, metabolically deranged and type 2 diabetes have
significantly correlated with kidney disease and vascular
damage in the adult population [22, 23]. Children and
adolescents represent a population subgroup where such
a noninvasive approach is the most desirable [24]. While
teenagers are old enough to refuse painful procedures,
most of time they are not mature enough to understand
the importance of routine screening tests [24]. Whereas
serum inflammatory markers have been studied in the
obese pediatric population [25–28], there is paucity of
data on urinary markers in the non-diabetic, overweight
and obese adolescent population.
The goal of the current study was to investigate urinary
biomarkers of ED and inflammation in overweight and
obese adolescents to provide a basis for non-invasive
screening and monitoring. We also compared endothelin
1 (ET-1), urinary biomarker of ED, with the previously
standardized noninvasive test RHI.
Methods
Study population
The study was approved by local IRB and informed consent
was obtained from all subjects before enrollment. Healthy
with within normal limit weight (NW), overweight (OW)
and obese adolescents (OA) were recruited from Texas
Tech University Health Science Center (TTUHSC)
pediatric clinics. CDC growth charts for the body mass
index (BMI) were used to classify the participants into
obese (BMI > 95%), overweight (BMI 85–95%) and sub-
jects with normal weight (BMI < 85%). Adolescents
from 10 to 20 years old were enrolled in the study. Both
informed consent and assent were obtained from the
legal guardian and the participant, who were younger
than 18 years old after explaining the goals of the study
and the potential risks. Informed consents were ob-
tained for participants 18 years and older. At the start
of the study, anthropometric (body height and weight),
biological (blood pressure, heart rate and physical fit-
ness), lifestyle (dietary habits, smoking behavior, and
daily physical activity), and psychological variables were
assessed. In addition, first morning fasting urine sam-
ples of the participants were collected, and biomarker
of endothelial dysfunction and four biomarkers of low-
grade inflammation were measured.
Assessment of endothelial dysfunction and low-grade
inflammation
Urinary biomarkers of endothelial dysfunction (ET-1), and
of low-grade inflammation (c-reactive protein (CRP),
alpha-1-acid glycoprotein (AGP), tumor necrosis factor-α
(TNF-α), and interleukin-6 were assessed by ELISA (R&D
Systems, Minneapolis, MN) per manufacture instructions.
All markers were normalized with urinary creatinine by
creatinine ELISA kit (R&D Systems, Minneapolis, MN).
Table 1 Age of participants
Male (n = 32) Female (n = 31) Total Age
NW 12 8 20 13.9 ± 2.0
OW 7 7 14 13.5 ± 2.4
OA 13 16 29 14.2 ± 2.5
Average 13.8 ± 2.3







NW Males 2.18 ± 0.92* 0.84 ± 0.39 2.65 ± 0.94
NW Females 2.0 ± 0.46 1.6 ± 0.84 2.18 ± 1.09
OW Males 1.75 ± 0.5 1.5 ± 0.7 1.83 ± 1.63
OW Females 2.5 ± 1.52 1.83 ± 1.52 2.16 ± 1.25
OA Males 4.07 ± 3.24*, ** 0.91 ± 0.66 2.93 ± 1.29
OA Females 2.04 ± 1.07** 1.54 ± 0.79 2.34 ± 0.80
NA Normal weight, OW Overweight, OA Obese; Data is presented
as Mean ± SD
*,** P < 0.05
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Reactive hyperemia index (RHI)
The Endo-PAT 2000 (Itamar 2000) machine was used in
measuring the RHI. Each participant was placed in a
quiet room with dim light and led to rest for 20 min be-
fore starting the procedure. The Endo-PAT probe was
placed on the index finger and a blood pressure cuff was
placed on the arm. A baseline reading was recorded
for 5 min then blood pressure cuff was inflated to
40 mm Hg above the systolic blood pressure for
5 min. Following this the machine recorded the readings
for 10 min and the Endo-PAT software calculated RHI
from the two readings.
Other measurements
Weight, height, body mass index, heart rate, and blood




Microsoft Excel spreadsheet to maintain the data was
used. For each parameter group means are presented
with the standard error of the mean as the index of
dispersion. Statistical significance was assessed using
analysis of variance followed by t-tests. Pearson’s cor-
relation was calculated between various study parame-
ters. Values of ‘p’ less than or equal to 0.05 were
considered statistically significant. Variables with a
skewed distribution (CRP, interleukin 6, TNF alpha,
ET-1 and AGP) were ranked using nonparametric
Wilcoxon-Whitney analysis. Overall z scores were cal-
culated for ED or low-grade inflammation. We also
calculated Receiver operating characteristics (ROC) by
Winnonlin software.
Results
Sixty three adolescents of 10–20 years age were included
in the study. There were 20 subjects in healthy normal
BMI group (NW), 14 subjects in overweight group
(OW), 29 subjects in obese group (OA) (Table 1).
Analysis of dietary habits with t-test shows that there
was no significant difference in carbohydrate, fat or pro-
tein consumption between normal, overweight and obese
adolescents. However obese male adolescents consumed
Fig. 1 a Comparison of median (min–max) urinary ET-1 (pg/mg) among normal weight (n = 20), overweight (n = 14) and obese (n = 29) group.
Data was compared by using tukey’s test. Data is represented as Whisker-box plot and outliers are plotted as individual points. b Median (min–max)
urinary ET-1 (pg/mg) among normal weight (n = 20), overweight (n = 14) and high risk obese (n = 17) group
Fig. 2 a Comparison of median (min–max) urinary TNF-α (pg/mg) among normal weight (n = 20), overweight (n = 14) and obese (n = 29) group.
Data was compared by using tukey’s test in combination with post-hoc analysis. Data is represented as Whisker-box plot and outliers are plotted
as individual points. b Median (min–max) urinary TNF-α (pg/mg) among normal weight (n = 20), overweight (n = 14) and high risk obese
(n = 17) group
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significantly more carbohydrates (average 4.07 ± 3.24 serv-
ings/day) as compared to obese female adolescents (2.04
± 1.07 servings/day), P = 0.039 (Table 2).
Obese males also consumed significantly more carbo-
hydrates (average 4.07 ± 3.24 servings/day) as compared
to normal weight male adolescents (average 2.18 ± 0.92),
P = 0.04, but there was no difference between carbohy-
drate consumption of normal weight and obese females.
With respect to clinical characteristics, obese adolescents
had a higher systolic BP percentile (average 77th ± 32.0
percentile) as compared with normal weight adolescents
(average 59th ± 19.8 percentile), P = 0.01 using t-test stat-
istical analysis. There was no significant difference in heart
rate among the three groups of adolescents. No statistical
significance was seen in ET-1 among OW (5.18 ±
1.6 pg/mg) as compared to NW (3.47 ± 0.3 pg/mg, P =
0.24) and among OA (8.48 ± 3.1 pg/mg) as compared to
NW (P = 0.19) and OW (P = 0.40) (Fig. 1). TNF-α was
significantly higher in OA (52.4 ± 15.3 pg/mg) com-
pared to NW (14.1 ± 1.2 pg/mg, P = 0.04) (Fig. 2). IL-6
levels were no different in OW (13.8 ± 3.2 pg/mg) or
in OA (15.8 ± 4.6 pg/mg) compared to NW (15.3 ± 2.9)
(P = 0.74, 0.93 respectively) (Fig. 3). Again, no differences in
AGP levels were seen in OW (864.8 ± 156 ng/mg) and OA
(808.3 ± 186 ng/mg) compared to NW (653 ± 69 ng/mg)
(P = 0.16, 0.49 respectively) (Fig. 4).
There was a group of obese individuals (58% of all
OA, n = 17) who had at least one inflammatory marker
more than one standard deviation above the standard
mean (Table 3). This group was segregated by Tukey’s
test, which identifies any difference between two
means that is greater than the expected standard
error. We identified this as a ‘high risk’ obese group
(HA) (Table 3).
Ten percent of these high risk obese adolescents (n = 3)
had elevation of all four inflammatory markers, namely
urinary ET-1, TNF-α, IL-6 and AGP. Of these, two were
males and one female. Upon comparing high risk obese
group individuals with NW and OW, ET-1, TNF-α, IL-6
and AGP were found to be significantly higher (Figs. 1b,
Fig. 3 a Comparison of median (min–max) urinary IL-6 (pg/mg) among normal weight (n = 20), overweight (n = 14) and obese (n = 29) group.
Data was compared by using tukey’s test in combination with post-hoc analysis. Data is represented as Whisker-box plot and outliers are plotted
as individual points. b Median (min–max) urinary IL-6 (pg/mg) among normal weight (n = 20), overweight (n = 14) and high risk obese
(n = 17) group
Fig. 4 a Comparison of median (min–max) urinary AGP (ng/mg) among normal weight (n = 20), overweight (n = 14) and obese (n = 29) group.
Data was compared by using tukey’s test in combination with post-hoc analysis. Data is represented as whisker-box plot and outliers are
plotted as individual points. b Median (min–max) urinary AGP (ng/mg) among normal weight (n = 20), overweight (n = 14) and high risk
obese (n = 17) group
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2b, 3b and 4b). No difference was observed in the RHI
compared with OW (1.66 ± 0.1) and NW (1.60 ± 0.1,
P = 0.78) or OA (1.67 ± 0.09) and HA (P = 0.65) (Fig. 5).
There was no statistically significant gender difference
in the urinary biomarkers of inflammation (urinary
TNF-α and urinary IL-6). However, sex difference was
observed in RHI values in healthy population with sig-
nificantly higher index in female compared to male
(Fig. 6a). ET-1 was also found significantly higher in
healthy female as compared to their male peers (Fig. 6b).
As shown in Fig. 7, the four inflammatory markers
were significantly and positively correlated. Significant
correlation was also observed when tested separately in
the subgroups (NW, OW, and OA). However RHI did
not show any significant correlation with inflammatory
markers (TNF-α r: 0.07, P = 0.50; IL-6 r: −0.07, P = 0.49;
ET-1 r: −0.02, P = 0.78; AGP r: −0.05 P = 0.58) (Fig. 7).
Discussion
Although measurement of reactive hyperemia was ad-
vocated for an adult population as a sensitive marker
of endothelial dysfunction [29, 30], in our study we did
not find significant difference in the RHI between
obese and adolescents with normal weight. In fact, the
RHI values in three groups were very close. Though
RHI did not show any significant correlation with the
urinary inflammatory markers, it could be possible that
changes in endothelial function as measured by RHI, is
a late finding in the inflammation to obesity to
cardiovascular disease development. Interestingly, we
observed sex based difference of this index in teen-
agers. Gender-related differences in healthy adults have
already been studied. The Framingham Heart Study re-
ported a lower PAT hyperemic response in males com-
pared to females, likely because estrogens stimulate
NO synthesis [31].
While this parameter is thought to be very sensitive in
the detecting ED in adults, our results question its sensi-
tivity in adolescents. Most likely, endothelial function in
obese adolescents is not compromised enough to pro-
duce significant difference on the finger plethysmogra-
phy. Thus this method, though non-invasive and
convenient, is not likely to be the first choice to monitor
the early changes in endothelial function.
Endothelin-1 is also a marker of endothelial dysfunc-
tion and potent vasoconstrictor, which is produced by
vascular endothelial cells. Urinary ET-1 earlier was found
to be elevated in adolescents with insulin dependent dia-
betes and was positively correlated with microalbuminuria
[32, 33]. Interestingly in adolescents with diabetes, serum
ET-1 was not found to be as sensitive [33] as other
authors determined it in urine [32].
In our study, ET-1 showed tendency to be higher in
OA, although it was not statistically significant. But this
observation should not be ignored due to the fact that
ET-1 showed significant and strong correlation with
urinary markers of inflammation, particularly TNF-α.
Analyzing urinary ET-1 is less time consuming for
patients and more cost efficient with comparable sensi-
tivity and specificity to RHI. We also observed sex dif-
ferences in levels of urinary ET-1 with the higher
number in adolescent girls. Looking for an explanation
of this finding, we found that a previous adult study ad-
dressed the sex difference in serum ET-1. Polderman et
al. showed that male hormones may increase plasma
endothelin levels, whereas female hormones can lower
them [32]. Another study showed contradictory results,
with plasma ET-1 levels significantly higher in women
than in men (7.1 ± 3.2 vs 4.5 ± 3.6; p < 0.01) [34]. It has
been reported that ET-1 is induced by agents known to
modulate calcium [35]. Thus estrogen would theoretic-
ally increase ET-1 levels [34]. We also observed similar
findings in our study with urinary excretion of ET-1.
AGP inflammatory marker significantly and positively
correlated with ET-1 and TNFα. This significant
Fig. 5 Comparison of mean (±SD) reactive hyperemia index (RHI)
among normal weight (n = 20), overweight (n = 14) and obese
(n = 29) group by t-test
Table 3 High risk obese group
All obese (n = 29) Percentage of OA with
ET-1 > 11.5 pg/mg
Percentage of OA with
TNF-α >67.6 pg/mg
Percentage of OA with
IL-6 > 20.4 pg/mg
Percentage of OA with
AGP >994.4 pg/mg
Males 14% (n = 4) 7% (n = 2) 7% (n = 2) 10% (n = 3)
Females 3% (n = 1) 3% (n = 1) 3% (n = 1) 7% (n = 2)
Total 17% (n = 5) 10% (n = 3) 10% (n = 3) 17% (n = 5)
OA Obese, ET-1 endothelin-1, TNF-α tumor necrosis factor-alpha, IL-6 interleukin-6, AGP alpha-1 acid glycoprotein
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correlation was also observed in different subgroups
based on BMI. The serum concentration of AGP rises
two to five times during an acute phase response and
changes its glycosylation pattern depending on the type
of inflammation [36]. The urinary level of TNF-α in obese
adolescents was significantly higher than counterparts
with normal weight and even in comparison to over-
weight adolescents. TNF-α is an inflammatory marker
that is well proved to be high in obese adult individuals
reflecting the subclinical systemic inflammation. Obese
Fig. 6 a Sex based comparison of Reactive Hyperemia Index (RHI) (mean ± SD) among normal weight (n = 20), overweight (n = 14), and obese
groups (n = 29) (**P <0.01). b Sex based comparison of ET-1 (mean ± SD) for endothelin 1 (ET-1) normal weight (n = 20), overweight (n = 14), and
obese groups (n = 29) (**P <0.01)
Fig. 7 Correlation between the different urinary biomarkers irrespective of age, weight and gender. N = 63. a Correlation of interleukin (IL-6) and
alpha 1 acid glycoprotein (AGP); b Correlation of interleukin (IL-6) and tumor necrosis factor alpha (TNF-α); c Correlation of interleukin (Il 6) and
endothelin 1 (ET-1); d Correlation of alpha 1 acid glycoprotein (AGP) and tumor necrosis factor alpha (TNF-α); e Correlation of alpha 1 acid
glycoprotein (AGP) and endothelin 1 (ET-1); f Correlation of tumor necrosis factor alpha (TNF α) and endothelin 1 (ET-1)
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teens have been shown to have chronic inflammation
and ED, by elevation of different serum markers [14,
17]. This study showed for the first time that in com-
parison with the other urinary markers, TNF-α is the
most sensitive marker to weight related body disorders.
Although we did not find a significant increase in the
other inflammatory markers in the urine of OA, namely
the IL-6 and orosomucoid, both showed tendency to be
higher and had a significant positive correlation with
TNF-α. A larger study with serum and urine levels
might be needed to accurately test the sensitivity of IL-6
and orosomucoid as urinary biomarkers for systemic
inflammation. In 2002 Wallenius found that IL-6 was in-
creased in obesity and responsible for insulin resistance
[37]. However the effect of IL-6 production involvement
in alteration in inflammatory signal is not fully known
[37]. The reason of gender difference and expression of
TNF alpha and IL-6 needs to be further investigated.
One reason may be that the most of the human studies
performed so far are cross-sectional studies or are case
control studies. There is need for prospective assessment
of these biomarkers. In present study, we found variability
in IL-6 values in obese group.
Conclusion
Urinary TNF-alpha is significantly elevated in obese ado-
lescents and correlates with urinary ET-1, which is rec-
ognized as a biomarker for endothelial dysfunction.
Since obesity is a chronic inflammatory state, elevated
urinary TNF-alpha might be used as a non invasive tool
to monitor the level of that inflammation. Urinary ET-1
is as sensitive test for ED as RHI. Sex differences exist in
healthy adolescents with normal weight in levels of urinary
ET-1 and RHI, which is blunted in overweight and obese
individuals.
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